BioCentury
ARTICLE | Company News

Competitive Technologies Inc., EpiTan, Melanotan Corp. deal

August 8, 2005 7:00 AM UTC

CTT licensed an additional patent covering melanogenesis-inducing technologies to Melanotan, which is the exclusive licensee of CTT's melanogenesis patent portfolio. The patent covers a series of cycl...